Suzanne E. Dahlberg

14.9k total citations · 4 hit papers
150 papers, 9.3k citations indexed

About

Suzanne E. Dahlberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Suzanne E. Dahlberg has authored 150 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Suzanne E. Dahlberg's work include Lung Cancer Treatments and Mutations (76 papers), Lung Cancer Research Studies (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Suzanne E. Dahlberg is often cited by papers focused on Lung Cancer Treatments and Mutations (76 papers), Lung Cancer Research Studies (28 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Suzanne E. Dahlberg collaborates with scholars based in United States, Canada and Israel. Suzanne E. Dahlberg's co-authors include Pasi A. Jänne, Geoffrey R. Oxnard, Joan H. Schiller, David M. Jackman, Lynette M. Sholl, Stephen E. Sallan, Lewis B. Silverman, Bruce E. Johnson, Mizuki Nishino and Mark M. Awad and has published in prestigious journals such as Circulation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Suzanne E. Dahlberg

142 papers receiving 9.2k citations

Hit Papers

Assessment of Resistance ... 2015 2026 2018 2022 2018 2016 2016 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
    2018 513 citations Geoffrey R. Oxnard, Daniel B. Costa et al. profile →
  2. MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
    2016 493 citations Geoffrey R. Oxnard, David M. Jackman et al. Journal of Clinical Oncology profile →
  3. Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
    2016 432 citations Cloud P. Paweletz, Suzanne E. Dahlberg et al. profile →
  4. Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers
    2015 348 citations Deepa Rangachari, Suzanne E. Dahlberg et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Suzanne E. Dahlberg 4.8k 4.7k 2.7k 1.7k 1.0k 150 9.3k
Martee L. Hensley 4.7k 1.0× 4.2k 0.9× 1.8k 0.7× 1.1k 0.6× 633 0.6× 223 13.3k
Steven G. DuBois 2.7k 0.6× 2.0k 0.4× 2.4k 0.9× 1.5k 0.9× 422 0.4× 281 7.4k
Anthony Elias 3.5k 0.7× 5.9k 1.2× 2.2k 0.8× 2.0k 1.2× 422 0.4× 205 9.8k
Bhumsuk Keam 4.0k 0.8× 6.1k 1.3× 2.1k 0.8× 1.6k 0.9× 546 0.5× 373 9.9k
Alberto S. Pappo 6.7k 1.4× 4.2k 0.9× 2.4k 0.9× 1.1k 0.7× 521 0.5× 308 11.6k
Mark L. Bernstein 2.7k 0.6× 1.8k 0.4× 2.2k 0.8× 776 0.5× 667 0.6× 184 7.5k
Graça M. Dores 1.9k 0.4× 2.9k 0.6× 1.6k 0.6× 1.2k 0.7× 806 0.8× 83 8.1k
Xuemei Wang 3.1k 0.6× 2.8k 0.6× 2.1k 0.8× 1.0k 0.6× 1.1k 1.1× 252 10.4k
Thierry Philip 3.3k 0.7× 4.8k 1.0× 2.3k 0.9× 1.1k 0.7× 1.3k 1.2× 277 12.0k
Michael Andersson 1.7k 0.4× 3.2k 0.7× 1000 0.4× 2.2k 1.3× 628 0.6× 123 7.6k

Countries citing papers authored by Suzanne E. Dahlberg

Since Specialization
Citations

This map shows the geographic impact of Suzanne E. Dahlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Dahlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Dahlberg more than expected).

Fields of papers citing papers by Suzanne E. Dahlberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne E. Dahlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Dahlberg. The network helps show where Suzanne E. Dahlberg may publish in the future.

Co-authorship network of co-authors of Suzanne E. Dahlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne E. Dahlberg. A scholar is included among the top collaborators of Suzanne E. Dahlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne E. Dahlberg. Suzanne E. Dahlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dahlberg, Suzanne E., et al.. (2024). Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes. Pediatric Transplantation. 28(1). e14665–e14665. 1 indexed citations
4.
Dahlberg, Suzanne E., et al.. (2024). Comparison of home‐based spirometry and oscillometry measurements in school‐age children with bronchopulmonary dysplasia. Pediatric Pulmonology. 59(10). 2589–2596. 1 indexed citations
5.
6.
Dahlberg, Suzanne E., et al.. (2022). Real‐world feasibility of short‐term, unsupervised home spirometry in CF. Pediatric Pulmonology. 57(12). 3129–3135. 16 indexed citations
7.
Berbert, Laura, Suzanne E. Dahlberg, Elana M. Bern, et al.. (2022). Eating disorders in adolescents and young adults with cystic fibrosis. Pediatric Pulmonology. 57(11). 2791–2797. 7 indexed citations
8.
Dahlberg, Suzanne E., et al.. (2021). Attitudes towards involving children in decision‐making surrounding lung transplantation. Pediatric Pulmonology. 56(6). 1534–1542. 2 indexed citations
9.
10.
Cooper, Alissa J., Yoshihisa Kobayashi, Dewey Kim, et al.. (2020). Identification of a RAS-activating TMEM87A–RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(15). 4072–4079. 14 indexed citations
11.
To, Ciric, Jaebong Jang, Ting Chen, et al.. (2019). Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor. Cancer Discovery. 9(7). 926–943. 250 indexed citations
12.
Russell‐Goldman, Eleanor, Sasha Kravets, Suzanne E. Dahlberg, Lynette M. Sholl, & Marina Vivero. (2018). Cytologic‐histologic correlation of programmed death‐ligand 1 immunohistochemistry in lung carcinomas. Cancer Cytopathology. 126(4). 253–263. 66 indexed citations
13.
Redig, Amanda J., Marzia Capelletti, Suzanne E. Dahlberg, et al.. (2016). Clinical and Molecular Characteristics of NF1 -Mutant Lung Cancer. Clinical Cancer Research. 22(13). 3148–3156. 53 indexed citations
14.
Yanagita, Masahiko, Amanda J. Redig, Cloud P. Paweletz, et al.. (2016). A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR -Mutant Non–Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial. Clinical Cancer Research. 22(24). 6010–6020. 92 indexed citations
15.
Calles, Antonio, Lynette M. Sholl, Scott J. Rodig, et al.. (2015). Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS -Mutant Lung Adenocarcinoma. Clinical Cancer Research. 21(12). 2851–2860. 86 indexed citations
16.
17.
Lipshultz, Steven E., Tracie L. Miller, Rebecca E. Scully, et al.. (2012). Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes. Journal of Clinical Oncology. 30(10). 1042–1049. 227 indexed citations
18.
Weigert, Oliver, Nadja Kopp, Andrew A. Lane, et al.. (2011). Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation. Cancer Discovery. 2(1). 47–55. 64 indexed citations
19.
Gutiérrez, Alejandro, Suzanne E. Dahlberg, Donna Neuberg, et al.. (2010). Absence of Biallelic TCR γ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 28(24). 3816–3823. 69 indexed citations
20.
Ramalingam, Suresh S., Suzanne E. Dahlberg, Corey J. Langer, et al.. (2007). Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599. Journal of Clinical Oncology. 26(1). 60–65. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martee L. Hensley Breakdown of academic impact, for papers by Steven G. DuBois Breakdown of academic impact, for papers by Anthony Elias Breakdown of academic impact, for papers by Bhumsuk Keam Breakdown of academic impact, for papers by Alberto S. Pappo Breakdown of academic impact, for papers by Mark L. Bernstein Breakdown of academic impact, for papers by Graça M. Dores Breakdown of academic impact, for papers by Xuemei Wang Breakdown of academic impact, for papers by Thierry Philip Breakdown of academic impact, for papers by Michael Andersson
Rankless by CCL
2026